SEARCH

SEARCH BY CITATION

References

  • 1
    Brown EG, Endersby CA, Smith RN, et al. The safety and tolerability of sumatriptan: a overview. Eur Neurol 1991; 31: 339 44.
  • 2
    Willett DF, Curzen N, Adams J, et al. Coronary vasospasm induced by subcutaneous sumatriptan. Br Med J 1992; 304: 14151415.
  • 3
    Castle WM & Simmons VE. Coronary vasospasm and sumatriptan. Br Med J 1992; 305: 117 18.
  • 4
    Curtin T, Brooks AP, Roberts JA. Cardiorespiratory distress after sumatriptan given by injection. Br Med J 1992; 305: 713 14.
  • 5
    Ottervanger JP, Paalman HJA, Boxma GL, et al. Transmural myocardial infarction with sumatriptan. Lancet 1993; 341: 861 2.
  • 6
    Boyd IW & Rohan AP. Sumatriptan-induced chest pain. Lancet 1994; 344: 1704 5.
  • 7
    O’Connor P & Gladstone P. Oral sumatriptan-associated transmural myocardial infarction. Neurology 1995; 45: 2274 6.
  • 8
    Kelly KM. Cardiac arrest following use of sumatriptan. Neurology 1995; 45: 1211 13.
  • 9
    Mueller L, Gallagher RM, Ciervo CA. Vasospasm-induced myocardial infarction with sumatriptan. Headache 1996; 36: 329 31.
  • 10
    MacIntyre PD, Bhargava B, Hogg KJ, et al. The effects of i.v. sumatriptan, a selective 5-HT1 receptor agonist on central haemodynamics and the coronary circulation. Br J Clin Pharmacol 1992; 34: 541 6.
  • 11
    MacIntyre PD, Bhargava B, Hogg KJ, et al. Effect of subcutaneous sumatriptan, a selective 5-HT1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation 1993; 87: 401 5.
  • 12
    Hillis WS & MacIntyre PD. Sumatriptan and chest pain. Lancet 1993; 341: 1564 5.
  • 13
    Evers S, Ingo-Wilhelm H, Enbergs A. Coronary angiography in migraine patient after subcutaneous sumatriptan. Lancet 1995; 345: 198198.
  • 14
    Peters L, Maas L, Petty D, et al. Spontaneous noncardiac chest pain. Evaluation by 24-hour ambulatory esophageal motility and pH monitoring. Gastroenterology 1988; 94: 878 86.
  • 15
    Lam HGT, Breumelhof R, Roelofs JMM, et al. What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data? Dig Dis Sci 1994; 39: 402 9.
  • 16
    Paterson WG, Abdollah H, Beck IT, et al. Ambulatory esophageal manometry, pH-metry, and holter ECG monitoring in patients with atypical chest pain. Dig Dis Sci 1993; 38: 795 802.
  • 17
    Houghton LA, Foster JM, Whorwell PJ, et al. Is chest pain after sumatriptan oesophageal in origin? Lancet 1994; 344: 985 6.
  • 18
    Mittal RK & McCallum RW. Characteristics of transient lower esophageal sphincter relaxation in humans. Am J Physiol 1987; 252(5 pt 1): G636 41.
  • 19
    Richter JE, Wu WC, Johns DN, et al. Esophageal manometry in 95 healthy volunteers. Variability of pressures with age and frequency of ‘abnormal’ contractions. Dig Dis Sci 1987; 32: 583 92.
  • 20
    Dooley CP, Di Lorenzo C, Valenzuela JE. Esophageal function in humans. Effects of bolus consistency and temperature. Dig Dis Sci 1990; 35: 167 72.
  • 21
    Clouse RE, Staiano A, Landau DW, et al. Manometric findings during spontaneous chest pain in patients with presumed esophageal ‘spasms’. Gastroenterology 1983; 85: 395 402.
  • 22
    Dent J, Holloway RH, Toouli J, et al. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastroesophageal reflux. Gut 1988; 29: 1020 8.
  • 23
    Murray JA, Ledlow A, Launspach J, et al. The effect of recombinant human haemoglobin on esophageal motor function in humans. Gastroenterology 1995; 109: 1241 8.
  • 24
    Bortolotti M, Annese V, Coccia G, et al. Twenty-four-hour ambulatory esophageal manometry in normal subjects. Neurogastroenterol Motil 1994; 6: 311 20.
  • 25
    Chester AH, O’Neil GS, Yaccoub MH. Sumatriptan and ischaemic heart disease. Lancet 1993; 341: 1419 20.
  • 26
    Edwards DAW. ‘Tender oesophagus’: a new syndrome. Gut 1982; 23: A919A919(Abstract).
  • 27
    Vantrappen G, Janssens J, Ghillebert G. The irritable oesophagus—a frequent cause of angina-like pain. Lancet 1987; 1: 1232 4.
  • 28
    Barish CF, Castell DO, Richter JE. Graded esophageal balloon distension. A new prospective test for noncardiac chest pain. Dig Dis Sci 1986; 31: 1292 8.
  • 29
    Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986; 91: 845 52.
  • 30
    Rao SSC, Gregerson H, Hayek B, et al. Unexplained chest pain: the hypersensitive, hyperreactive and poorly complaint oesophagus. Ann Intern Med 1996; 124: 950 8.
  • 31
    De Caestecker JS, Pryde A, Heading RC. Site and mechanism of pain perception with oesophageal balloon distension and intravenous edrophonium in patients with oesophageal chest pain. Gut 1992; 33: 580 6.
  • 32
    Foster JM, Houghton LA, Whorwell PJ. Further evidence that sumatriptan induced chest pain is oesophageal in origin: effect on oesophageal visceral sensation. Gastroenterology 1997; 112: A653A653(Abstract).
  • 33
    Plosker GL & McTavish D. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 1994; 47: 622 51.
  • 34
    Henderson JM, Lidgard G, Osborne DH, et al. Lower oesophageal sphincter response to gastrin—pharmacological or physiological? Gut 1978; 19: 99 102.
  • 35
    Cohen S & Lipshulz W. Hormonal regulation of human lower esophageal sphincter competence: interaction of gastrin and secretin. J Clin Invest 1971; 50: 449 54.
  • 36
    Christensen J. Patterns and origin of some esophageal responses to stretch and electrical stimulation. Gastroenterology 1970; 59: 909 16.
  • 37
    Tack JF, Coulie B, Wilmer A, et al. Sumatriptan, a 5-HT1-receptor agonist, causes a significant relaxation of the gastric fundus in man . Gastroenterology 1995; 108: A580A580(Abstract).
  • 38
    Coulie B, Tack J, Broekaert D, et al. Motor patterns underlying the delay in gastric emptying during 5-HT1 receptor activation in man. Gastroenterology 1997; 112: A502A502(Abstract).
  • 39
    Holloway RH, Hongo M, Berger K, et al. Gastric distension: a mechanism for postprandial gastroesophageal reflux. Gastroenterology 1985; 89: 779 84.
  • 40
    Beattie DT, Connor HE, Feniuk W, et al. The pharmacology of sumatriptan. Rev Contemp Pharmacother 1994; 5: 285 94.
  • 41
    Kaumann AJ, Parsons AA, Brown AM. Human arterial constrictor serotonin receptors. Cardiovasc Res 1993; 27: 2094 103.
  • 42
    Humphrey PPA, Feniuk W, Perren MJ, et al. The pharmacology of the novel 5-HT1-like receptor agonist. GR43175 . Cephalalgia 1989; 9(Suppl. 9): 23 33.
  • 43
    Castro ME, Pascual J, Romon T, et al. Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord. Neuropharmacology 1997; 36: 535 42.
  • 44
    Sleight AJ, Cervenka A, Peroutka SJ. In vivo effects of sumatriptan (GR43175) on extracellular levels of 5-HT in the guinea-pig. Neuropharmacology 1990; 29: 511 13.